CITIUS PHARMACEUTICALS INC
CTXR·17322U306·US·Common Stock·Healthcare - Biotechnology-13D/G
CTXR (CITIUS PHARMACEUTICALS INC) is held by 23 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($221,556), VANGUARD CAPITAL MANAGEMENT LLC ($150,964), VANGUARD FIDUCIARY TRUST CO ($69,980). Net institutional sentiment: Mixed.
23
Holders
Avg rating(6 Elite)
$733,373
Total Value
58% (26)
Fund Consensus
11 buying - 8 selling
13F: Insider & Congress:
Showing 1-20 of 26
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer